Quality Management (QM) & cGMP Lab Dashboard
ECC T-Codes: QA32 / QE51N / QA03Analytical release testing, Certificates of Analysis (CoA), In-Process Quality Control (IPQC), and stability chambers.
PIC/S Lab Status:Zero Critical Deviations
CoA Turnaround
18.4 Hours-2.2h
Sample to signoff<24h
Right First Time
99.2%+0.4%
Assays passed 1st run>98.5%
Active OOS Incidents
0 Open0
Zero deviationsLimit: 0
Stability Chambers
48 Batches+3
ICH zone conditions100% On-Time
In-Process Lots
14 Lots+1
IPQC testing queueActive
Micro Testing Passed
100%0
Bioburden & endotoxinSterile
HPLC/GC Uptime
98.6%+0.8%
Chromatography systems>95%
cGMP Audit Score
Grade A0
Regulatory compliancePIC/S / FDA
Inspection Lot Disposition & Release Breakdown
Real-time status of commercial batch release dossiers
Released (CoA Ready): 76%
In-Process Testing: 14%
Stability 3M/6M: 8%
Pending Review: 2%
Inspection Lots & Analytical Testing Queue
(5 Inspection Lots)| Inspection Lot | Sample Material Description | Batch Number | QC Stage | Assay Progress | TAT | Lead Analyst | CoA Status | Lot Disposition |
|---|---|---|---|---|---|---|---|---|
| QL-09941 | Paracetamol 500mg (Batch BMR-2610-A14) | BMR-2610-A14 | In-Process QC | 6 / 6 Tests | 8.5 hrs | Dr. M. Santos, RCh | Pending Signoff | Compliant |
| QL-09938 | Sterile Water for Injection (Batch BMR-2610-S01) | BMR-2610-S01 | Finished Product Release | 8 / 8 Tests | 48 hrs | K. Villanueva, Micro Lead | Signed & Issued | Released (CoA Ready) |
| QL-09945 | Amoxicillin Trihydrate Compacted BP Raw API | LOT-INSP-AMX-99 | Raw Material Testing | 4 / 5 Tests | 14.2 hrs | R. Tan, Analytical Chemist | Pending Signoff | Pending Review |
| QL-09920 | Ascorbic Acid + Zinc Tablet 500mg | BMR-2609-V12 | Stability Chamber 3M | 7 / 7 Tests | 72 hrs | A. De Leon, Stability Head | Signed & Issued | Compliant |
| QL-09950 | Hard Blister Foil Lot 25mc Printed | LOT-ALU-089 | Raw Material Testing | 2 / 3 Tests | 6 hrs | J. Corpuz, Packaging QA | Pending Signoff | Pending Review |